Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;37(8):1571-1578.
doi: 10.1111/jgh.15878. Epub 2022 May 11.

Evaluating diagnostic performance of Truenat MTB Plus for gastrointestinal tuberculosis

Kusum Sharma  1 , Megha Sharma  1   2 , Vishal Sharma  3 , Megha Sharma  3 , Jayanta Samanta  3 , Aman Sharma  4 , Rakesh Kochhar  3 , Saroj Kant Sinha  3
Affiliations

Evaluating diagnostic performance of Truenat MTB Plus for gastrointestinal tuberculosis

Kusum Sharma et al. J Gastroenterol Hepatol. 2022 Aug.

Abstract

Background and aim: Prompt and accurate diagnosis of gastrointestinal tuberculosis (GITB) along with simultaneous detection of drug resistance is inevitable for tuberculosis elimination. Truenat MTB Plus (TruPlus), a chip-based real-time polymerase chain reaction assay, was evaluated for the first time for diagnosing GITB and detecting rifampicin resistance.

Methods: Fifty ileocecal biopsy specimens (5 microbiologically confirmed GITB [culture-positive], 25 clinically confirmed GITB [culture-negative], and 20 control patients) processed in the Department of Microbiology between 2011 and 2021 were subjected to TruPlus assay, Xpert MTB RIF assay multiplex polymerase chain reaction. Their performance was evaluated against both culture and composite reference standard.

Results: The overall sensitivity and specificity of TruPlus in diagnosing GITB was 70% (21/30) and 100%, respectively. The sensitivity was 60% (3/5) for microbiologically confirmed cases and 72% (18/25) for clinically confirmed cases. Performance of TruPlus was superior to Xpert (sensitivity = 30%; P = 0.001) and comparable with MPCR (sensitivity = 83.33%; P = 0.13). Both TruPlus and MPCR had moderate agreement with reference standards, and MPCR detected additional three cases. Both TruPlus and Xpert correctly reported Rifampicin resistance in three cases.

Conclusions: TruPlus, with its greater portability and higher sensitivity than Xpert, could serve as an important tool for diagnosing GITB and rifampicin resistance at outreach endemic areas.

Keywords: IS6110; Truenat; Xpert MTB/RIF; abdominal tuberculosis.

PubMed Disclaimer

References

    1. World Health Organization. The top 10 causes of death from 2000 to 2019. 2020. Available from URL: https://www.who.int/news-room/fact-sheets/detail/t Accessed 21 March 2022.
    1. World Health Organisation (WHO). Global Tuberculosis Report 2019. Geneva: World Health Organization, 2019.
    1. Chakaya J, Khan M, Ntoumi F et al. Global tuberculosis report 2020-reflections on the global TB burden, treatment and prevention efforts. Int. J. Infect. Dis. 2021; 113: 4-9. https://doi.org/10.1016/j.ijid.2021.02.107
    1. Manuel A, Lim Z, Wiggins J. Gastrointestinal tuberculosis: a diagnosis not to miss. J. R. Coll. Physicians Edinb. 2010; 40: 209-212. https://doi.org/10.4997/JRCPE.2010.305
    1. Khan R, Abid S, Jafri W et al. Diagnostic dilemma of abdominal tuberculosis in non-HIV patients: an ongoing challenge for physicians. World J. Gastroenterol. 2006; 12: 6371-6375. https://doi.org/10.3748/wjg.v12.i39.6371

MeSH terms

LinkOut - more resources